Net gamma exposure for Intellia Therapeutics Inc (NTLA) options was positive at the Nov 4, 2026 close, about $299.97K per 1% move in the stock. It has been positive on 20 of the last 20 trading days. With positive gamma, dealer hedging tends to lean against price moves, which can dampen swings.
Upgrade to unlock Gamma Flip, Gamma Profile, Call Wall, Put Wall, and multiple expiration dates.
Gamma Exposure by Strike
Showing results for NTLA, 2026-11-20(m), calls & puts
Gamma Exposure Stats
Showing results for NTLA, 2026-11-20(m), calls & puts
Net Gamma Exposure by Expiration
Showing results for NTLA, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net GEX | Call GEX | Put GEX | Call Wall | Put Wall | Gamma Flip |
|---|
NTLA Gamma Exposure FAQ
What is gamma exposure (GEX)?
Gamma exposure estimates how much stock option dealers must buy or sell to stay hedged for each 1% move in the underlying.
Is NTLA gamma exposure positive or negative?
Intellia Therapeutics net gamma exposure was positive on Nov 4, 2026, at $299.97K. It has been positive on 20 of the last 20 trading days.
How has NTLA gamma exposure changed recently?
Intellia Therapeutics net gamma exposure went from $262.63K on Oct 7, 2026 to $299.97K on Nov 4, 2026. See the NTLA gamma exposure history for a longer view.
What is Intellia Therapeutics Inc?
Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics.